143 related articles for article (PubMed ID: 25920563)
1. Novel synthetic bisbenzimidazole that targets angiogenesis in Ehrlich ascites carcinoma bearing mice.
Roopashree R; Mohan CD; Swaroop TR; Jagadish S; Raghava B; Balaji KS; Jayarama S; Basappa ; Rangappa KS
Bioorg Med Chem Lett; 2015 Jun; 25(12):2589-93. PubMed ID: 25920563
[TBL] [Abstract][Full Text] [Related]
2. Antiangiogenic and antiproliferative effects of substituted-1,3,4-oxadiazole derivatives is mediated by down regulation of VEGF and inhibition of translocation of HIF-1alpha in Ehrlich ascites tumor cells.
Kumar A; D'Souza SS; Nagaraj SR; Gaonkar SL; Salimath BP; Rai KM
Cancer Chemother Pharmacol; 2009 Nov; 64(6):1221-33. PubMed ID: 19370348
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of new coumarin tethered isoxazolines as potential anticancer agents.
Lingaraju GS; Balaji KS; Jayarama S; Anil SM; Kiran KR; Sadashiva MP
Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3606-3612. PubMed ID: 30396758
[TBL] [Abstract][Full Text] [Related]
4. Punarnavine, an alkaloid from Boerhaavia diffusa exhibits anti-angiogenic activity via downregulation of VEGF in vitro and in vivo.
Saraswati S; Alhaider AA; Agrawal SS
Chem Biol Interact; 2013 Nov; 206(2):204-13. PubMed ID: 24060680
[TBL] [Abstract][Full Text] [Related]
5. Ursolic acid inhibits tumor angiogenesis and induces apoptosis through mitochondrial-dependent pathway in Ehrlich ascites carcinoma tumor.
Saraswati S; Agrawal SS; Alhaider AA
Chem Biol Interact; 2013 Nov; 206(2):153-65. PubMed ID: 24051192
[TBL] [Abstract][Full Text] [Related]
6. LQFM030 reduced Ehrlich ascites tumor cell proliferation and VEGF levels.
da Mota MF; de Carvalho FS; de Ávila RI; de Ávila PHM; Cortez AP; Menegatti R; Sabino JR; Dos Santos TRM; Gomes SA; da Cunha LC; Valadares MC
Life Sci; 2018 May; 201():1-8. PubMed ID: 29278686
[TBL] [Abstract][Full Text] [Related]
7. A new acridine derivative induces cell cycle arrest and antiangiogenic effect on Ehrlich ascites carcinoma model.
Mangueira VM; Batista TM; Brito MT; Sousa TKG; Cruz RMDD; Abrantes RA; Veras RC; Medeiros IA; Medeiros KKP; Pereira ALDC; Serafim VL; Moura RO; Sobral MV
Biomed Pharmacother; 2017 Jun; 90():253-261. PubMed ID: 28364597
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and tumor inhibitory activity of novel coumarin analogs targeting angiogenesis and apoptosis.
Vijay Avin BR; Thirusangu P; Lakshmi Ranganatha V; Firdouse A; Prabhakar BT; Khanum SA
Eur J Med Chem; 2014 Mar; 75():211-21. PubMed ID: 24534537
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, angiopreventive activity, and in vivo tumor inhibition of novel benzophenone-benzimidazole analogs.
Ranganatha VL; Vijay Avin BR; Thirusangu P; Prashanth T; Prabhakar BT; Khanum SA
Life Sci; 2013 Nov; 93(23):904-11. PubMed ID: 24135459
[TBL] [Abstract][Full Text] [Related]
10. Modulation of tumor induced angiogenesis in Ehrlich ascites tumor.
Ghosh S; Roy S; Banerjee M; Maity P
J Exp Clin Cancer Res; 2004 Dec; 23(4):681-90. PubMed ID: 15743040
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxic and antitumor effects of brucine on Ehrlich ascites tumor and human cancer cell line.
Agrawal SS; Saraswati S; Mathur R; Pandey M
Life Sci; 2011 Aug; 89(5-6):147-58. PubMed ID: 21684292
[TBL] [Abstract][Full Text] [Related]
12. Novel Synthetic Indazoles Abrogate Angiogenesis in Erlich Ascites Tumor Bearing Mice.
Ashwini N; Balaji KS; Sadashivaiah BL; Swaroop TR; Jayarama S; Mantelingu K; Rangappa KS
Anticancer Agents Med Chem; 2023; 23(17):1924-1931. PubMed ID: 37469157
[TBL] [Abstract][Full Text] [Related]
13. Anti-angiogenic effect of resveratrol or curcumin in Ehrlich ascites carcinoma-bearing mice.
El-Azab M; Hishe H; Moustafa Y; El-Awady el-S
Eur J Pharmacol; 2011 Feb; 652(1-3):7-14. PubMed ID: 21114990
[TBL] [Abstract][Full Text] [Related]
14. Antitumoral and antiangiogenic activity of Synadenium umbellatum Pax.
Nogueira IA; Leão AB; Vieira Mde S; Benfica PL; da Cunha LC; Valadares MC
J Ethnopharmacol; 2008 Dec; 120(3):474-8. PubMed ID: 18805473
[TBL] [Abstract][Full Text] [Related]
15. Antiangiogenic and proapoptotic activities of allyl isothiocyanate inhibit ascites tumor growth in vivo.
Kumar A; D'Souza SS; Tickoo S; Salimath BP; Singh HB
Integr Cancer Ther; 2009 Mar; 8(1):75-87. PubMed ID: 19223371
[TBL] [Abstract][Full Text] [Related]
16. Antiangiogenic and proapoptotic activity of a novel glycoprotein from U. indica is mediated by NF-kappaB and Caspase activated DNase in ascites tumor model.
Deepak AV; Salimath BP
Biochimie; 2006; 88(3-4):297-307. PubMed ID: 16216405
[TBL] [Abstract][Full Text] [Related]
17. Novel prodrugs of tegafur that display improved anticancer activity and antiangiogenic properties.
Engel D; Nudelman A; Tarasenko N; Levovich I; Makarovsky I; Sochotnikov S; Tarasenko I; Rephaeli A
J Med Chem; 2008 Jan; 51(2):314-23. PubMed ID: 18163551
[TBL] [Abstract][Full Text] [Related]
18. Identification of Novel Bisbenzimidazole Derivatives as Anticancer Vacuolar (H⁺)-ATPase Inhibitors.
Patil R; Kulshrestha A; Tikoo A; Fleetwood S; Katara G; Kolli B; Seibel W; Gilman-Sachs A; Patil SA; Beaman KD
Molecules; 2017 Sep; 22(9):. PubMed ID: 28926955
[TBL] [Abstract][Full Text] [Related]
19. Quinazoline-based multi-tyrosine kinase inhibitors: synthesis, modeling, antitumor and antiangiogenic properties.
Conconi MT; Marzaro G; Urbani L; Zanusso I; Di Liddo R; Castagliuolo I; Brun P; Tonus F; Ferrarese A; Guiotto A; Chilin A
Eur J Med Chem; 2013 Sep; 67():373-83. PubMed ID: 23900004
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and antitumor evaluation of novel thalidomide dithiocarbamate and dithioate analogs against Ehrlich ascites carcinoma-induced solid tumor in Swiss albino mice.
Zahran MA; Salem TA; Samaka RM; Agwa HS; Awad AR
Bioorg Med Chem; 2008 Nov; 16(22):9708-18. PubMed ID: 18951804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
